Clinical Trial Update: A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities [Phase 3]

View source ↗

Summary

Phase 3 study comparing simultaneous vs sequential application of ingenol mebutate gel (0.015% and 0.05%) for actinic keratosis on the face/scalp and trunk/extr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Ingenol Mebutate Gel 0.05% (ingenol mebutate)
• Ingenol Mebutate Gel, 0.015% (ingenol mebutate)

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2015-05-07